Finally, to improve the prediction of postoperative recurrence in HCC patients following neoadjuvant immunotherapy, we integrated MVI, tumor capsule, and CD4+ T cell density of the CT region to construct a nomogram model (Figure 3D). This evidence concerns the gene CD4 and hepatocellular carcinoma.